Skip to content
Screener

Achieve Life Sciences ACHV Q1 2025 earnings

Reported May 13, 2025 · Before market open

EPS-$0.37In line
EPS estimate-$0.37

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$10.6M
EPS estimate-$0.20

Financials

Q1 2025

Income statement

See full
Net income-$12.8M-97.5%
EPS (diluted)-$0.37-42.3%

Balance sheet

See full
Cash & equivalents$13.0M-80.4%
Total debt$1.3M-92.4%
Total equity$10.3M-79.2%
Total assets$27.4M-60.9%

Cash flow

See full
Operating cash flow-$11.1M-110%
CapEx$750.0—
Free cash flow-$12.4M—

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$92.61M-40.5%
Enterprise value$80.9M-24.0%

Returns & leverage

See full
Return on equity-154.5%+108pp
Debt / equity0.1×-0.2×
Current ratio3.5×+0.2×

FAQ

When did Achieve Life Sciences report Q1 2025 earnings?
Achieve Life Sciences (ACHV) reported Q1 2025 earnings on May 13, 2025 before market open.
What were Achieve Life Sciences's Q1 2025 revenue and EPS?
Achieve Life Sciences reported eps of $-0.37 for Q1 2025.
Did Achieve Life Sciences beat estimates in Q1 2025?
EPS beat the consensus estimate of $-0.37 by $0.00.
How did Achieve Life Sciences's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 42.3% from $-0.26.
Where can I find Achieve Life Sciences's Q1 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-069804) and the 10-Q periodic report (0000950170-25-069806) directly on SEC EDGAR. The filing index links above go to sec.gov.